 Shares of Cardinal Health Inc. CAH, 0.83 jumped 4.4 toward a five-year high in premarket trading Friday, after the drug and laboratory products distributor reported fiscal first-quarter profit and revenue that beat expectations, as strength in generics and branded pharmaceuticals helped offset inflationary supply chain costs. Net income for the quarter to Sept. 